Granulocyte Colony Stimulating Factor Receptor, Recombinant, Mouse, His-Tag (G-CSFR, CD114)
Catalog No : USB-G8950-50N
682.78€
0.00€
Shipping cost plus VAT not included , delivery in 7-14 business days
| Product name | Granulocyte Colony Stimulating Factor Receptor, Recombinant, Mouse, His-Tag (G-CSFR, CD114) | ||
|---|---|---|---|
| Catalog No | USB-G8950-50N | ||
| Supplier’s Catalog No | G8950-50N | ||
| Supplier | US Biologicals | ||
| Source antigen | Recombinant, Mouse, NSO cells | ||
| Reactivity | |||
| Cross reactivity | |||
| Applications | |||
| Molecular weight | |||
| Storage | -20°C | ||
|---|---|---|---|
| Other names | |||
| Grade | Highly Purified | ||
| Purity | ~95% (SDS-PAGE) | ||
| Form | Supplied as a lyophilized powder from PBS, Trehalose. Reconstitute with 500ul sterile PBS. | ||
| Reactivity life | 12 months | ||
| Note | For reserch purpose only | ||
| Purity | ~95% (SDS-PAGE) | ||
| Description | Granulocyte colony stimulating factor (G-CSF) is a pleiotropic cytokine best known for its specific effects on the proliferation, differentiation, and activation of hematopoietic cells of the neutrophilic and granulocyte lineage (1). G-CSF plays an important role in defense against infection, in inflammation and repair, and in the maintenance of steady state hematopoiesis. Cell activation by G‑CSF is mediated by granulocyte colony stimulating factor receptor alpha (G-CSF R; also CD114), a 95 ‑ 105 kDa type I transmembrane protein and member of the cytokine receptor superfamily, type I cytokine receptor family, and type 2 subfamily of receptor proteins. Mouse G‑CSF R is synthesized as an 837 amino acid (aa) precursor that contains a 25 aa signal sequence, a 601 aa extracellular domain (ECD), a 24 aa transmembrane region, and a 187 aa cytoplasmic tail. The ECD contains one Ig-like C2-type domain, five fibronectin type-III domains, and 11 potential sites for N-linked glycosylation. Within the ECD there is also a WSXWS motif (aa 319 ‑ 323) that is necessary for proper protein folding and thereby efficient intracellular transport and cell-surface receptor binding (2). Also, within the cytoplasmic domain there is a Box 1 motif which is required for JAK interaction and/or activation (1). Mouse G‑CSF R shares 63% aa sequence identity with human G‑CSF R. G-CSF R is expressed in mature neutrophils, neutrophilic precursors, myeloid leukemia cells, and placenta (1). Mutations have been found in the gene encoding G-CSF R in some patients with severe congenital neutropenia (1). These mutations typically lead to a truncation in the cytoplasmic domain of the G-CSF R leading to maturation arrest of neutrophilic precursors in the bone marrow and neutropenia in peripheral blood (3). Binding of G-CSF to its receptor induces dimerization or oligomerization of the receptor activating cytoplasmic tyrosine kinases (2). Signal transduction from pathways that involve Janus tyrosine kinases/signal transducer and activator of transcription proteins (Jak1, Jak2, and Tyk2/STAT3 and STATG), src-related protein tyrosine kinases (Lyn and Syk), Ras/MAP kinase, and phosphatidylinositol have been reported to be activated upon G-CSF stimulation (4). Source: Recombinant protein corresponding to Met1-Asp626 from mouse GCSF R/CD114, C-terminal, 6-His tag expressed in NSO cells. Molecular Weight: ~68.2kD Biological Activity: Measured by its ability to inhibit the G-CSF-induced proliferation of NFS-60 mouse myeloid cells. The ED50 for this effect is typically 0.02-0.12ug/ml in the presence of 0.125ng/mL of recombinant mouse G-CSF. Endotoxin Level: <1EU/ug (LAL method) Storage and Stability: Lyophilized powder may be stored at -20°C. Stable for 12 months at -20°C. Reconstitute with sterile buffer. Aliquot to avoid repeated freezing and thawing. Store at -20°C. Reconstituted product is stable for 6 months at -20°C. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap. Further dilutions can be made in assay buffer. | ||
Product Details
© 2020 Imugex All Rights Reserved